ABBOTT LABORATORIES T.ABT

Primary Symbol: ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

NYSE:ABT - Post by User

ABBOTT LABORATORIES

Bullboard Posts

Post by eljoroon May 24, 2016 4:00pm

75 Views

Post# 24900620

Insider buy: May 19th

Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price May 20/16 May 19/16 Rosenfeld, Eric Stuart Control or Direction Common Shares 10 - Acquisition in the public market 5,000 $6.41
May 20/16 May 18/16 Rosenfeld, Eric Stuart Control or Direction Common Shares 10 - Acquisition in the public market 8,200 $6.42 -

Bullboard Posts

Eminent acquires promising Nevada gold project